Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis

Frontiers in Cellular and Infection Microbiology

Volumn 4, Issue MAY, 2013, Pages

  Gomez, Gabriel ^a   Adams, Leslie G ^a   Rice Ficht, Allison ^a,b   Ficht, Thomas A ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Antigen discovery; Brucellosis; Intracellular pathogens; Reverse vaccinology; Subunit vaccine; Vaccines

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIBIOTIC AGENT; BRUCELLA VACCINE; CALNEXIN; CALRETICULIN; CPG OLIGODEOXYNUCLEOTIDE; IMIQUIMOD; INTERLEUKIN 10; LIVE VACCINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; O ANTIGEN; RAB7 PROTEIN; SUBUNIT VACCINE; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL ANTIGEN; BACTERIAL VACCINE; VACCINE;

ADAPTIVE IMMUNITY; ANTIGEN MEDIATED CLONAL SELECTION; BACTERIAL GENOME; BRUCELLOSIS; CELL MIGRATION; CELLULAR IMMUNITY; GENE EXPRESSION; GENE REPLICATION; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INFECTION CONTROL; INTERNALIZATION; MOLECULAR PATHOLOGY; NONHUMAN; REVIEW; VACCINATION; ANIMAL; BRUCELLA; DRUG DEVELOPMENT; GENETICS; GENOMICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; ANTIGEN DISCOVERY; INTRACELLULAR PATHOGENS; METHODOLOGY; REVERSE VACCINOLOGY;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BRUCELLA; BRUCELLOSIS; DRUG DISCOVERY; GENOME, BACTERIAL; GENOMICS; HOST-PATHOGEN INTERACTIONS; HUMANS; VACCINES, SUBUNIT;

ANTIGEN DISCOVERY; BRUCELLOSIS; INTRACELLULAR PATHOGENS; REVERSE VACCINOLOGY; SUBUNIT VACCINE; VACCINES;

EID: 84891395860     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2013.00017     Document Type: Review

References (187)

1. Adams, L. G. (2002). The pathology of brucellosis reflects the outcome of the battle between the host genome and the Brucella genome. Vet. Microbiol. 90, 553-561.
2. Alix, E., Mukherjee, S., and Roy, C. R. (2011). Subversion of membrane transport pathways by vacuolar pathogens. J. Cell Biol. 195, 943-952.
3. Al-Mariri, A. (2010). Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein. Vaccine 28, 1766-1770.
4. Al-Mariri, A., Mahmoud, N. H., and Hammoud, R. (2012). Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice. Biologicals 40, 140-145.
5. Al-Mariri, A., Tibor, A., Mertens, P., De Bolle, X., Michel, P., Godefroid, J., et al. (2001). Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect. Immun. 69, 4816-4822.
6. Araya, L. N., Elzer, P. H., Rowe, G. E., Enright, F. M., and Winter, A. J. (1989). Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 143, 3330-3337.
7. Ashford, D. A., di Pietra, J., Lingappa, J., Woods, C., Noll, H., Neville, B., et al. (2004). Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 22, 3435-3439.
8. Atluri, V. L., Xavier, M. N., de Jong, M. F., den Hartigh, A. B., and Tsolis, R. E. (2011). Interactions of the human pathogenic Brucella species with their hosts. Annu. Rev. Microbiol. 65, 523-541.
9. Bagnoli, F., Baudner, B., Mishra, R. P., Bartolini, E., Fiaschi, L., Mariotti, P., et al. (2011). Designing the next generation of vaccines for global public health. OMICS 15, 545-566.
10. Baldwin, C. L., and Parent, M. (2002). Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Vet. Microbiol. 90, 367-382.
11. Barquero-Calvo, E., Conde-Alvarez, R., Chacon-Diaz, C., Quesada-Lobo, L., Martirosyan, A., Guzman-Verri, C., et al. (2009). The differential interaction of Brucella and Ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens. PLoS ONE 4:e5893. doi: 10.1371/journal.pone.0005893
12. Barrionuevo, P., Cassataro, J., Delpino, M. V., Zwerdling, A., Pasquevich, K. A., Garcia Samartino, C., et al. (2008). Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2. Infect. Immun. 76, 250-262.
13. Bessoles, S., Ni, M., Garcia-Jimenez, S., Sanchez, F., and Lafont, V. (2011). Role of NKG2D and its ligands in the anti-infectious activity of Vgamma9Vdelta2 T cells against intracellular bacteria. Eur. J. Immunol. 41, 1619-1628.
14. Bhattacharjee, A. K., Izadjoo, M. J., Zollinger, W. D., Nikolich, M. P., and Hoover, D. L. (2006). Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine. Infect. Immun. 74, 5820-5825.
15. Billard, E., Cazevieille, C., Dornand, J., and Gross, A. (2005). High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect. Immun. 73, 8418-8424.
16. Billard, E., Dornand, J., and Gross, A. (2007). Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion. Infect. Immun. 75, 4980-4989.
17. Blanchard, N., and Shastri, N. (2010). Cross-presentation of peptides from intracellular pathogens by MHC class I molecules. Ann. N.Y. Acad. Sci. 1183, 237-250.
18. Blasco, J. M., and Diaz, R. (1993). Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet 342, 805.
19. Bos, M. P., Robert, V., and Tommassen, J. (2007). Biogenesis of the gram-negative bacterial outer membrane. Annu. Rev. Microbiol. 61, 191-214.
20. Boschiroli, M. L., Ouahrani-Bettache, S., Foulongne, V., Michaux-Charachon, S., Bourg, G., Allardet-Servent, A., et al. (2002). The Brucella suis virB operon is induced intracellularly in macrophages. Proc. Natl. Acad. Sci. U.S.A. 99, 1544-1549.
21. Bosio, C. M., and Dow, S. W. (2005). Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175, 6792-6801.
22. Bossi, P., Tegnell, A., Baka, A., Van Loock, F., Hendriks, J., Werner, A., et al. (2004). Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Euro Surveill. 9, E15-E16.
23. Brandao, A. P., Oliveira, F. S., Carvalho, N. B., Vieira, L. Q., Azevedo, V., Macedo, G. C., et al. (2012). Host susceptibility to Brucella abortus infection is more pronounced in IFN-gamma knockout than IL-12/beta2-microglobulin double-deficient mice. Clin. Dev. Immunol. 2012:589494. doi: 10.1155/2012/589494
24. Briones, G., Inon de Iannino, N., Roset, M., Vigliocco, A., Paulo, P. S., and Ugalde, R. A. (2001). Brucella abortus cyclic beta-1, 2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells. Infect. Immun. 69, 4528-4535.
25. Campbell, G. A., Adams, L. G., and Sowa, B. A. (1994). Mechanisms of binding of Brucella abortus to mononuclear phagocytes from cows naturally resistant or susceptible to brucellosis. Vet. Immunol. Immunopathol. 41, 295-306.
26. Carle, A., Hoppner, C., Ahmed Aly, K., Yuan, Q., den Dulk-Ras, A., Vergunst, A., et al. (2006). The Brucella suis type IV secretion system assembles in the cell envelope of the heterologous host Agrobacterium tumefaciens and increases IncQ plasmid pLS1 recipient competence. Infect. Immun. 74, 108-117.
27. Casadevall, A., and Pirofski, L. A. (2006). A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv. Immunol. 91, 1-44.
28. Cassataro, J., Estein, S. M., Pasquevich, K. A., Velikovsky, C. A., de la Barrera, S., Bowden, R., et al. (2005). Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect. Immun. 73, 8079-8088.
29. Cassataro, J., Velikovsky, C. A., Bruno, L., Estein, S. M., de la Barrera, S., Bowden, R., et al. (2007). Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin. Vaccine Immunol. 14, 869-874.
30. Castaneda-Roldan, E. I., Ouahrani-Bettache, S., Saldana, Z., Avelino, F., Rendon, M. A., Dornand, J., et al. (2006). Characterization of SP41, a surface protein of Brucella associated with adherence and invasion of host epithelial cells. Cell Microbiol. 8, 1877-1887.
31. Celli, J., de Chastellier, C., Franchini, D. M., Pizarro-Cerda, J., Moreno, E., and Gorvel, J. P. (2003). Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198, 545-556.
32. Celli, J., Salcedo, S. P., and Gorvel, J. P. (2005). Brucella coopts the small GTPase Sar1 for intracellular replication. Proc. Natl. Acad. Sci. U.S.A. 102, 1673-1678.
33. Chaudhary, A., Ganguly, K., Cabantous, S., Waldo, G. S., Micheva-Viteva, S. N., Nag, K., et al. (2012). The Brucella TIR-like protein TcpB interacts with the death domain of MyD88. Biochem. Biophys. Res. Commun. 417, 299-304.
34. Chen, C., Dow, C., Wang, P., Sidney, J., Read, A., Harmsen, A., et al. (2011). Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses. PLoS ONE 6:e17712. doi: 10.1371/journal.pone.0017712
35. Chen, D. J., Osterrieder, N., Metzger, S. M., Buckles, E., Doody, A. M., DeLisa, M. P., et al. (2010). Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc. Natl. Acad. Sci. U.S.A. 107, 3099-3104.
36. Chomel, B. B., DeBess, E. E., Mangiamele, D. M., Reilly, K. F., Farver, T. B., Sun, R. K., et al. (1994). Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J. Infect. Dis. 170, 1216-1223.
37. Cloeckaert, A., Vizcaino, N., Paquet, J. Y., Bowden, R. A., and Elzer, P. H. (2002). Major outer membrane proteins of Brucella spp.: past, present and future. Vet. Microbiol. 90, 229-247.
38. Coffman, R. L., Sher, A., and Seder, R. A. (2010). Vaccine adjuvants: putting innate immunity to work. Immunity 33, 492-503.
39. Corbel, M. J. (1976). The immunogenic activity of ribosomal fractions derived from Brucella abortus. J. Hyg. (Lond.) 76, 65-74.
40. Corbel, M. J., World Health Organization, Food and Agriculture Organization of the United Nations, International Office of Epizootics, and ebrary Inc. (2006). Brucellosis in Humans and Animals. Geneva: World Health Organization.
41. Cossart, P., and Roy, C. R. (2010). Manipulation of host membrane machinery by bacterial pathogens. Curr. Opin. Cell Biol. 22, 547-554.
42. Czibener, C., and Ugalde, J. E. (2012). Identification of a unique gene cluster of Brucella spp. that mediates adhesion to host cells. Microbes Infect. 14, 79-85.
43. David, R. (2012). Cellular microbiology: an unconventional exit for Brucella. Nat. Rev. Microbiol. 10, 160.
44. de Jong, M. F., Sun, Y. H., den Hartigh, A. B., van Dijl, J. M., and Tsolis, R. M. (2008). Identification of VceA and VceC, two members of the VjbR regulon that are translocated into macrophages by the Brucella type IV secretion system. Mol. Microbiol. 70, 1378-1396.
45. den Hartigh, A. B., Rolan, H. G., de Jong, M. F., and Tsolis, R. M. V. (2008). VirB3 to VirB6 and VirB8 to VirB11, but not VirB7, are essential for mediating persistence of Brucella in the reticuloendothelial system. J. Bacteriol. 190, 4427-4436.
46. de Veer, M., and Meeusen, E. (2011). New developments in vaccine research-unveiling the secret of vaccine adjuvants. Discov. Med. 12, 195-204.
47. Duewell, P., Kisser, U., Heckelsmiller, K., Hoves, S., Stoitzner, P., Koernig, S., et al. (2011). ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. J. Immunol. 187, 55-63.
48. Durward, M., Radhakrishnan, G., Harms, J., Bareiss, C., Magnani, D., and Splitter, G. A. (2012). Active evasion of CTL mediated killing and low quality responding CD8+ T cells contribute to persistence of Brucellosis. PLoS ONE 7:e34925. doi: 10.1371/journal.pone.0034925
49. Eckman, M. R. (1975). Brucellosis linked to Mexican cheese. JAMA 232, 636-637.
50. Elzer, P. H., Jacobson, R. H., Jones, S. M., Nielsen, K. H., Douglas, J. T., and Winter, A. J. (1994). Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology 82, 651-658.
51. Eriksson, S., Lucchini, S., Thompson, A., Rhen, M., and Hinton, J. C. (2003). Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol. Microbiol. 47, 103-118.
52. Estevan, M., Gamazo, C., Grillo, M. J., Del Barrio, G. G., Blasco, J. M., and Irache, J. M. (2006). Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice. Vaccine 24, 4179-4187.
53. Falagas, M. E., and Bliziotis, I. A. (2006). Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob. Agents Chemother. 50, 22-33.
54. Fernandes, D. M., Benson, R., and Baldwin, C. L. (1995). Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice. Infect. Immun. 63, 4029-4033.
55. Ficht, T. A., Kahl-McDonagh, M. M., Arenas-Gamboa, A. M., and Rice-Ficht, A. C. (2009). Brucellosis: the case for live, attenuated vaccines. Vaccine 27(Suppl. 4), D40-D43.
56. Finco, O., Frigimelica, E., Buricchi, F., Petracca, R., Galli, G., Faenzi, E., et al. (2011). Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc. Natl. Acad. Sci. U.S.A. 108, 9969-9974.
57. Fontan, P., Aris, V., Ghanny, S., Soteropoulos, P., and Smith, I. (2008). Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection. Infect. Immun. 76, 717-725.
58. Franco, M. P., Mulder, M., Gilman, R. H., and Smits, H. L. (2007). Human brucellosis. Lancet Infect. Dis. 7, 775-786.
59. Frey, J. (2007). Biological safety concepts of genetically modified live bacterial vaccines. Vaccine 25, 5598-5605.
60. Fu, S., Xu, J., Li, X., Xie, Y., Qiu, Y., Du, X., et al. (2012). Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection. PLoS ONE 7:e29552. doi: 10.1371/journal.pone.0029552
61. Fugier, E., Salcedo, S. P., de Chastellier, C., Pophillat, M., Muller, A., Arce-Gorvel, V., et al. (2009). The glyceraldehyde-3-phosphate dehydrogenase and the small GTPase Rab 2 are crucial for Brucella replication. PLoS Pathog. 5:e1000487. doi: 10.1371/journal.ppat.1000487
62. Fukuto, H. S., Svetlanov, A., Palmer, L. E., Karzai, A. W., and Bliska, J. B. (2010). Global gene expression profiling of Yersinia pestis replicating inside macrophages reveals the roles of a putative stress-induced operon in regulating type III secretion and intracellular cell division. Infect. Immun. 78, 3700-3715.
63. Galen, J. E., Pasetti, M. F., Tennant, S., Ruiz-Olvera, P., Sztein, M. B., and Levine, M. M. (2009). Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunol. Cell. Biol. 87, 400-412.
64. Gao, N., Jennings, P., Guo, Y., and Yuan, D. (2011). Regulatory role of natural killer (NK) cells on antibody responses to Brucella abortus. Innate Immun. 17, 152-163.
65. Garcia Samartino, C., Delpino, M. V., Pott Godoy, C., Di Genaro, M. S., Pasquevich, K. A., Zwerdling, A., et al. (2010). Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis. Am. J. Pathol. 176, 1323-1338.
66. Giambartolomei, G. H., Delpino, M. V., Cahanovich, M. E., Wallach, J. C., Baldi, P. C., Velikovsky, C. A., et al. (2002). Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. J. Infect. Dis. 186, 252-259.
67. Glynn, M. K., and Lynn, T. V. (2008). Brucellosis. J. Am. Vet. Med. Assoc. 233, 900-908.
68. Godfroid, J., Cloeckaert, A., Liautard, J. P., Kohler, S., Fretin, D., Walravens, K., et al. (2005). From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet. Res. 36, 313-326.
69. Goel, D., and Bhatnagar, R. (2012). Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544. Mol. Immunol. 51, 159-168.
70. Goenka, R., Parent, M. A., Elzer, P. H., and Baldwin, C. L. (2011). B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus. J. Infect. Dis. 203, 1136-1146.
71. Golding, B., Scott, D. E., Scharf, O., Huang, L. Y., Zaitseva, M., Lapham, C., et al. (2001). Immunity and protection against Brucella abortus. Microbes Infect. 3, 43-48.
72. Gorvel, J. P., and Moreno, E. (2002). Brucella intracellular life: from invasion to intracellular replication. Vet. Microbiol. 90, 281-297.
73. Grillo, M. J., Blasco, J. M., Gorvel, J. P., Moriyon, I., and Moreno, E. (2012). What have we learned from brucellosis in the mouse model? Vet. Res. 43, 29.
74. Gross, A., Terraza, A., Ouahrani-Bettache, S., Liautard, J. P., and Dornand, J. (2000). In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect. Immun. 68, 342-351.
75. Gupta, V. K., Radhakrishnan, G., Harms, J., and Splitter, G. (2012). Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis. Vaccine 30, 4017-4022.
76. Guzman-Verri, C., Manterola, L., Sola-Landa, A., Parra, A., Cloeckaert, A., Garin, J., et al. (2002). The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc. Natl. Acad. Sci. U.S.A. 99, 12375-12380.
77. Haag, A. F., Myka, K. K., Arnold, M. F., Caro-Hernandez, P., and Ferguson, G. P. (2010). Importance of Lipopolysaccharide and Cyclic beta-1, 2-Glucans in Brucella-Mammalian Infections. Int. J. Microbiol. 2010:124509. doi: 10.1155/2010/124509
78. Harms, J. S., Durward, M. A., Magnani, D. M., and Splitter, G. A. (2009). Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella. J. Immune Based Ther. Vaccines. 7:1. doi: 10.1186/1476-8518-7-1
79. He, Y., Reichow, S., Ramamoorthy, S., Ding, X., Lathigra, R., Craig, J. C., et al. (2006). Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages. Infect. Immun. 74, 5035-5046.
80. He, Y., Xiang, Z., and Mobley, H. L. (2010). Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J. Biomed. Biotechnol. 2010:297505. doi: 10.1155/2010/297505
81. Hernandez-Castro, R., Verdugo-Rodriguez, A., Puente, J. L., and Suarez-Guemes, F. (2008). The BMEI0216 gene of Brucella melitensis is required for internalization in HeLa cells. Microb. Pathog. 44, 28-33.
82. Hoffmann, E. M., and Houle, J. J. (1995). Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host. Crit. Rev. Microbiol. 21, 153-163.
83. Hong, P. C., Tsolis, R. M., and Ficht, T. A. (2000). Identification of genes required for chronic persistence of Brucella abortus in mice. Infect. Immun. 68, 4102-4107.
84. Hybiske, K., and Stephens, R. S. (2008). Exit strategies of intracellular pathogens. Nat. Rev. Microbiol. 6, 99-110.
85. Iwasaki, A. (2007). Mucosal dendritic cells. Annu. Rev. Immunol. 25, 381-418.
86. Jain, S., Afley, P., and Kumar, S. (2012). Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice. World J. Microbiol. Biotechnol. 29, 907-913.
87. Jain-Gupta, N., Contreras-Rodriguez, A., Vemulapalli, R., Witonsky, S. G., Boyle, S. M., and Sriranganathan, N. (2012). Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice. FEMS Immunol. Med. Microbiol. 66, 436-444.
88. Jimenez de Bagues, M. P., Terraza, A., Gross, A., and Dornand, J. (2004). Different responses of macrophages to smooth and rough Brucella spp.: relationship to virulence. Infect. Immun. 72, 2429-2433.
89. Jubier-Maurin, V., Boigegrain, R. A., Cloeckaert, A., Gross, A., Alvarez-Martinez, M. T., Terraza, A., et al. (2001). Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages. Infect. Immun. 69, 4823-4830.
90. Kamath, A. T., Rochat, A. F., Christensen, D., Agger, E. M., Andersen, P., Lambert, P. H., et al. (2009). A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PLoS ONE 4:e5771. doi: 10.1371/journal.pone.0005771
91. Kao, F. F., Mahmuda, S., Pinto, R., Triccas, J. A., West, N. P., and Britton, W. J. (2012). The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice. PLoS ONE 7:e34991. doi: 10.1371/journal.pone.0034991
92. Karunakaran, K. P., Yu, H., Foster, L. J., and Brunham, R. C. (2010). Development of a Chlamydia trachomatis T cell Vaccine. Hum. Vaccin. 6, 676-680.
93. Ko, J., and Splitter, G. A. (2003). Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16, 65-78.
94. Laloux, G., Deghelt, M., de Barsy, M., Letesson, J. J., and De Bolle, X. (2010). Identification of the essential Brucella melitensis porin Omp2b as a suppressor of Bax-induced cell death in yeast in a genome-wide screening. PLoS ONE 5:e13274. doi: 10.1371/journal.pone.0013274
95. Lamontagne, J., Butler, H., Chaves-Olarte, E., Hunter, J., Schirm, M., Paquet, C., et al. (2007). Extensive cell envelope modulation is associated with virulence in Brucella abortus. J. Proteome Res. 6, 1519-1529.
96. Lapaque, N., Forquet, F., de Chastellier, C., Mishal, Z., Jolly, G., Moreno, E., et al. (2006). Characterization of Brucella abortus lipopolysaccharide macrodomains as mega rafts. Cell. Microbiol. 8, 197-206.
97. Lapaque, N., Moriyon, I., Moreno, E., and Gorvel, J. P. (2005). Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 8, 60-66.
98. Levitz, S. M., and Golenbock, D. T. (2012). Beyond empiricism: informing vaccine development through innate immunity research. Cell 148, 1284-1292.
99. Li, X., Xu, J., Xie, Y., Qiu, Y., Fu, S., Yuan, X., et al. (2012). Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB/c mice. Vet. Microbiol. 161, 137-144.
100. Liang, L., Leng, D., Burk, C., Nakajima-Sasaki, R., Kayala, M. A., Atluri, V. L., et al. (2010). Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens. PLoS Negl. Trop. Dis. 4:e673. doi: 10.1371/journal.pntd.0000673
101. Liebenberg, J., Pretorius, A., Faber, F. E., Collins, N. E., Allsopp, B. A., and van Kleef, M. (2012). Identification of Ehrlichia ruminantium proteins that activate cellular immune responses using a reverse vaccinology strategy. Vet. Immunol. Immunopathol. 145, 340-349.
102. Lowry, J. E., Isaak, D. D., Leonhardt, J. A., Vernati, G., Pate, J. C., and Andrews, G. P. (2011). Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection. PLoS ONE 6:e17425. doi: 10.1371/journal.pone.0017425
103. Lucchini, S., Liu, H., Jin, Q., Hinton, J. C., and Yu, J. (2005). Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen. Infect. Immun. 73, 88-102.
104. Lucero, N. E., Ayala, S. M., Escobar, G. I., and Jacob, N. R. (2008). Brucella isolated in humans and animals in Latin America from 1968 to 2006. Epidemiol. Infect. 136, 496-503.
105. Mallick, A. I., Singha, H., Chaudhuri, P., Nadeem, A., Khan, S. A., Dar, K. A., et al. (2007). Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection. Vaccine 25, 3692-3704.
106. Manterola, L., Guzman-Verri, C., Chaves-Olarte, E., Barquero-Calvo, E., de Miguel, M. J., Moriyon, I., et al. (2007). BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence. Infect. Immun. 75, 4867-4874.
107. Mantur, B. G., Amarnath, S. K., and Shinde, R. S. (2007). Review of clinical and laboratory features of human brucellosis. Indian J. Med. Microbiol. 25, 188-202.
108. Marchesini, M. I., Herrmann, C. K., Salcedo, S. P., Gorvel, J. P., and Comerci, D. J. (2011). In search of Brucella abortus type IV secretion substrates: screening and identification of four proteins translocated into host cells through VirB system. Cell Microbiol. 13, 1261-1274.
109. Martin, C. (2005). The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Eur. Respir. J. 26, 162-167.
110. Martin-Martin, A. I., Caro-Hernandez, P., Orduna, A., Vizcaino, N., and Fernandez-Lago, L. (2008). Importance of the Omp25/Omp31 family in the internalization and intracellular replication of virulent B. ovis in murine macrophages and HeLa cells. Microbes Infect. 10, 706-710.
111. Martin-Martin, A. I., Vizcaino, N., and Fernandez-Lago, L. (2010). Cholesterol, ganglioside GM1 and class A scavenger receptor contribute to infection by Brucella ovis and Brucella canis in murine macrophages. Microbes Infect. 12, 246-251.
112. McMurry, J. A., Kimball, S., Lee, J. H., Rivera, D., Martin, W., Weiner, D. B., et al. (2007). Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice. Curr. Mol. Med. 7, 351-368.
113. Moreno, E., and Moriyon, I. (2002). Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc. Natl. Acad. Sci. U.S.A. 99, 1-3.
114. Moriyon, I., and Lopez-Goni, I. (1998). Structure and properties of the outer membranes of Brucella abortus and Brucella melitensis. Int. Microbiol. 1, 19-26.
115. Munoz, P. M., Estevan, M., Marin, C. M., Jesus De Miguel, M., Jesus Grillo, M., Barberan, M., et al. (2006). Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams. Vaccine 24, 1897-1905.
116. Murphy, E., Robertson, G. T., Parent, M., Hagius, S. D., Roop, R. M. 2nd., Elzer, P. H., et al. (2002). Major histocompatibility complex class I and II expression on macrophages containing a virulent strain of Brucella abortus measured using green fluorescent protein-expressing brucellae and flow cytometry. FEMS Immunol. Med. Microbiol. 33, 191-200.
117. Murphy, E. A., Sathiyaseelan, J., Parent, M. A., Zou, B., and Baldwin, C. L. (2001). Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103, 511-518.
118. Nijskens, C., Copin, R., De Bolle, X., and Letesson, J. J. (2008). Intracellular rescuing of a B. melitensis 16M virB mutant by co-infection with a wild type strain. Microb. Pathog. 45, 134-141.
119. O'Callaghan, D., Cazevieille, C., Allardet-Servent, A., Boschiroli, M. L., Bourg, G., Foulongne, V., et al. (1999). A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol. Microbiol. 33, 1210-1220.
120. Oliveira, S. C., and Splitter, G. A. (1995). CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur. J. Immunol. 25, 2551-2557.
121. Oliveira, S. C., and Splitter, G. A. (1996). Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14, 959-962.
122. Oyewumi, M. O., Kumar, A., and Cui, Z. (2010). Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev. Vaccines 9, 1095-1107.
123. Pakzad, I., Rezaee, A., Rasaee, M. J., Tabbaraee, B., and Delpisheh, A. (2009). Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model. Iran J. Immunol. 6, 12-21.
124. Pappas, G., Akritidis, N., Bosilkovski, M., and Tsianos, E. (2005). Brucellosis. N. Engl. J. Med. 352, 2325-2336.
125. Pasquevich, K. A., Estein, S. M., Garcia Samartino, C., Zwerdling, A., Coria, L. M., Barrionuevo, P., et al. (2009). Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect. Immun. 77, 436-445.
126. Pasquevich, K. A., Ibanez, A. E., Coria, L. M., Garcia Samartino, C., Estein, S. M., Zwerdling, A., et al. (2011). An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS ONE 6:e16203. doi: 10.1371/journal.pone.0016203
127. Pei, J., Turse, J. E., and Ficht, T. A. (2008). Evidence of Brucella abortus OPS dictating uptake and restricting NF-kappaB activation in murine macrophages. Microbes Infect. 10, 582-590.
128. Perkins, S. D., Smither, S. J., and Atkins, H. S. (2010). Towards a Brucella vaccine for humans. FEMS Microbiol. Rev. 34, 379-394.
129. Pizarro-Cerda, J., Moreno, E., Sanguedolce, V., Mege, J. L., and Gorvel, J. P. (1998). Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect. Immun. 66, 2387-2392.
130. Plotkin, S. A. (2010). Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17, 1055-1065.
131. Porte, F., Naroeni, A., Ouahrani-Bettache, S., and Liautard, J. P. (2003). Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages. Infect. Immun. 71, 1481-1490.
132. Posadas, D. M., Ruiz-Ranwez, V., Bonomi, H. R., Martin, F. A., and Zorreguieta, A. (2012). BmaC, a novel autotransporter of Brucella suis, is involved in bacterial adhesion to host cells. Cell Microbiol. 14, 965-982.
133. Pruneau, L., Emboule, L., Gely, P., Marcelino, I., Mari, B., Pinarello, V., et al. (2012). Global gene expression profiling of Ehrlichia ruminantium at different stages of development. FEMS Immunol. Med. Microbiol. 64, 66-73.
134. Qin, Q. M., Pei, J., Ancona, V., Shaw, B. D., Ficht, T. A., and de Figueiredo, P. (2008). RNAi screen of endoplasmic reticulum-associated host factors reveals a role for IRE1alpha in supporting Brucella replication. PLoS Pathog. 4:e1000110. doi: 10.1371/journal.ppat.1000110
135. Radhakrishnan, G. K., Harms, J. S., and Splitter, G. A. (2011). Modulation of microtubule dynamics by a TIR domain protein from the intracellular pathogen Brucella melitensis. Biochem. J. 439, 79-83.
136. Radhakrishnan, G. K., Yu, Q., Harms, J. S., and Splitter, G. A. (2009). Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP. J. Biol. Chem. 284, 9892-9898.
137. Rafiei, A., Ardestani, S. K., Kariminia, A., Keyhani, A., Mohraz, M., and Amirkhani, A. (2006). Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. J. Infect. 53, 315-324.
138. Rappuoli, R. (2000). Reverse vaccinology. Curr. Opin. Microbiol. 3, 445-450.
139. Rice-Ficht, A. C., Arenas-Gamboa, A. M., Kahl-McDonagh, M. M., and Ficht, T. A. (2010). Polymeric particles in vaccine delivery. Curr. Opin. Microbiol. 13, 106-112.
140. Rockx-Brouwer, D., Chong, A., Wehrly, T. D., Child, R., Crane, D. D., Celli, J., et al. (2012). Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination. PLoS ONE 7:e37752. doi: 10.1371/journal.pone.0037752
141. Rollenhagen, C., Sorensen, M., Rizos, K., Hurvitz, R., and Bumann, D. (2004). Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. Proc. Natl. Acad. Sci. U.S.A. 101, 8739-8744.
142. Rollier, C. S., Reyes-Sandoval, A., Cottingham, M. G., Ewer, K., and Hill, A. V. (2011). Viral vectors as vaccine platforms: deployment in sight. Curr. Opin. Immunol. 23, 377-382.
143. Roset, M. S., Ciocchini, A. E., Ugalde, R. A., and Inon de Iannino, N. (2004). Molecular cloning and characterization of cgt, the Brucella abortus cyclic beta-1, 2-glucan transporter gene, and its role in virulence. Infect. Immun. 72, 2263-2271.
144. Rossetti, C. A., Galindo, C. L., Garner, H. R., and Adams, L. G. (2011). Transcriptional profile of the intracellular pathogen Brucella melitensis following HeLa cells infection. Microb. Pathog. 51, 338-344.
145. Saez, D., Fernandez, P., Rivera, A., Andrews, E., and Onate, A. (2012). Oral immunization of mice with recombinant Lactococcus lactis expressing Cu, Zn superoxide dismutase of Brucella abortus triggers protective immunity. Vaccine 30, 1283-1290.
146. Salcedo, S. P., Marchesini, M. I., Lelouard, H., Fugier, E., Jolly, G., Balor, S., et al. (2008). Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog. 4:e21. doi: 10.1371/journal.ppat.0040021
147. Scholz, H. C., Nockler, K., Gollner, C., Bahn, P., Vergnaud, G., Tomaso, H., et al. (2010). Brucella inopinata sp. nov., isolated from a breast implant infection. Int. J. Syst. Evol. Microbiol. 60, 801-808.
148. Schurig, G. G., Sriranganathan, N., and Corbel, M. J. (2002). Brucellosis vaccines: past, present and future. Vet. Microbiol. 90, 479-496.
149. Seder, R. A., and Hill, A. V. (2000). Vaccines against intracellular infections requiring cellular immunity. Nature 406, 793-798.
150. Seleem, M. N., Boyle, S. M., and Sriranganathan, N. (2010). Brucellosis: a re-emerging zoonosis. Vet. Microbiol. 140, 392-398.
151. Sengupta, D., Koblansky, A., Gaines, J., Brown, T., West, A. P., Zhang, D., et al. (2010). Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL. J. Immunol. 184, 956-964.
152. Sette, A., and Rappuoli, R. (2010). Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33, 530-541.
153. Shannon, J. G., and Heinzen, R. A. (2009). Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Immunol. Res. 43, 138-148.
154. Skendros, P., Boura, P., Chrisagis, D., and Raptopoulou-Gigi, M. (2007). Diminished percentage of CD4+ T-lymphocytes expressing interleukine-2 receptor alpha in chronic brucellosis. J. Infect. 54, 192-197.
155. Skendros, P., Pappas, G., and Boura, P. (2011). Cell-mediated immunity in human brucellosis. Microbes Infect. 13, 134-142.
156. Skyberg, J. A., Thornburg, T., Rollins, M., Huarte, E., Jutila, M. A., and Pascual, D. W. (2011). Murine and bovine gammadelta T cells enhance innate immunity against Brucella abortus infections. PLoS ONE 6:e21978. doi: 10.1371/journal.pone.0021978
157. Sola-Landa, A., Pizarro-Cerda, J., Grillo, M. J., Moreno, E., Moriyon, I., Blasco, J. M., et al. (1998). A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol. Microbiol. 29, 125-138.
158. Spera, J. M., Ugalde, J. E., Mucci, J., Comerci, D. J., and Ugalde, R. A. (2006). A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc. Natl. Acad. Sci. U.S.A. 103, 16514-16519.
159. Starr, T., Child, R., Wehrly, T. D., Hansen, B., Hwang, S., Lopez-Otin, C., et al. (2012). Selective subversion of autophagy complexes facilitates completion of the Brucella intracellular cycle. Cell Host Microbe 11, 33-45.
160. Starr, T., Ng, T. W., Wehrly, T. D., Knodler, L. A., and Celli, J. (2008). Brucella intracellular replication requires trafficking through the late endosomal/lysosomal compartment. Traffic 9, 678-694.
161. Sundaramurthi, J. C., Brindha, S., Shobitha, S. R., Swathi, A., Ramanandan, P., and Hanna, L. E. (2012). In silico identification of potential antigenic proteins and promiscuous CTL epitopes in Mycobacterium tuberculosis. Infect. Genet. Evol. 12, 1312-1318.
162. Tabatabai, L. B., and Pugh, G. W. Jr. (1994). Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine 12, 919-924.
163. Taylor, J. P., and Perdue, J. N. (1989). The changing epidemiology of human brucellosis in Texas, 1977-1986. Am. J. Epidemiol. 130, 160-165.
164. Titball, R. W. (2008). Vaccines against intracellular bacterial pathogens. Drug Discov. Today 13, 596-600.
165. Turse, J. E., Pei, J., and Ficht, T. A. (2011). Lipopolysaccharide-deficient Brucella variants arise spontaneously during infection. Front. Microbiol. 2:54. doi: 10.3389/fmicb.2011.00054
166. Velasquez, L. N., Delpino, M. V., Ibanez, A. E., Coria, L. M., Miraglia, M. C., Scian, R., et al. (2012). Brucella abortus induces apoptosis of human T lymphocytes. Microbes Infect. 14, 639-650.
167. Velikovsky, C. A., Goldbaum, F. A., Cassataro, J., Estein, S., Bowden, R. A., Bruno, L., et al. (2003). Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect. Immun. 71, 5750-5755.
168. Viadas, C., Rodriguez, M. C., Sangari, F. J., Gorvel, J. P., Garcia-Lobo, J. M., and Lopez-Goni, I. (2010). Transcriptome analysis of the Brucella abortus BvrR/BvrS two-component regulatory system. PLoS ONE 5:e10216. doi: 10.1371/journal.pone.0010216
169. Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., et al. (2011). Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49.
170. von Bargen, K., Gorvel, J. P., and Salcedo, S. P. (2012). Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol. Rev. 36, 533-562.
171. Waag, D. M., England, M. J., Tammariello, R. F., Byrne, W. R., Gibbs, P., Banfield, C. M., et al. (2002). Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20, 2623-2634.
172. Waddell, S. J., and Butcher, P. D. (2007). Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis. Curr. Mol. Med. 7, 287-296.
173. Wallach, J. C., Ferrero, M. C., Victoria Delpino, M., Fossati, C. A., and Baldi, P. C. (2008). Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina. Clin. Microbiol. Infect. 14, 805-807.
174. Wang, Y., Chen, Z., Qiao, F., Ying, T., Yuan, J., Zhong, Z., et al. (2009). Comparative proteomics analyses reveal the virB of B. melitensis affects expression of intracellular survival related proteins. PLoS ONE 4:e5368. doi: 10.1371/journal.pone.0005368
175. Watanabe, K., Tachibana, M., Tanaka, S., Furuoka, H., Horiuchi, M., Suzuki, H., et al. (2008). Heat shock cognate protein 70 contributes to Brucella invasion into trophoblast giant cells that cause infectious abortion. BMC Microbiol. 8:212. doi: 10.1186/1471-2180-8-212
176. Watarai, M., Makino, S., Fujii, Y., Okamoto, K., and Shirahata, T. (2002). Modulation of Brucella-induced macropinocytosis by lipid rafts mediates intracellular replication. Cell Microbiol. 4, 341-355.
177. Wattam, A. R., Williams, K. P., Snyder, E. E., Almeida, N. F. Jr., Shukla, M., Dickerman, A. W., et al. (2009). Analysis of ten Brucella genomes reveals evidence for horizontal gene transfer despite a preferred intracellular lifestyle. J. Bacteriol. 191, 3569-3579.
178. Wehrly, T. D., Chong, A., Virtaneva, K., Sturdevant, D. E., Child, R., Edwards, J. A., et al. (2009). Intracellular biology and virulence determinants of Francisella tularensis revealed by transcriptional profiling inside macrophages. Cell Microbiol. 11, 1128-1150.
179. Williams, E. (1970). Brucellosis and the British public. Lancet 1, 1220-1222.
180. Wu, Q., Pei, J., Turse, C., and Ficht, T. A. (2006). Mariner mutagenesis of Brucella melitensis reveals genes with previously uncharacterized roles in virulence and survival. BMC Microbiol. 6:102. doi: 10.1186/1471-2180-6-102
181. Yang, Y., Wang, L., Yin, J., Wang, X., Cheng, S., Lang, X., et al. (2011a). Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine. Mol. Immunol. 49, 175-184.
182. Yang, Y., Yin, J., Guo, D., Lang, X., and Wang, X. (2011b). Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection. FEMS Immunol. Med. Microbiol. 61, 159-167.
183. Yingst, S., and Hoover, D. L. (2003). T cell immunity to brucellosis. Crit. Rev. Microbiol. 29, 313-331.
184. Zhan, Y., and Cheers, C. (1995). Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63, 1387-1390.
185. Zhan, Y., Liu, Z., and Cheers, C. (1996). Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect. Immun. 64, 2782-2786.
186. Zhao, Z., Yan, F., Ji, W., Luo, D., Liu, X., Xing, L., et al. (2011). Identification of immunoreactive proteins of Brucella melitensis by immunoproteomics. Sci. China Life Sci. 54, 880-887.
187. Zvi, A., Rotem, S., Bar-Haim, E., Cohen, O., and Shafferman, A. (2011). Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response. PLoS ONE 6:e20050. doi: 10.1371/journal.pone.0020050